Cargando…

Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors

Vasohibin‐1 (VASH1) is a negative feedback regulator of angiogenesis, the first to be discovered, and was identified in vascular endothelial growth factor (VEGF)‐stimulated vascular endothelial cells. Vasohibin‐1 inhibits abnormal vascularization induced by various angiogenic factors including fibro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Yoshifumi, Saga, Yasushi, Koyanagi, Takahiro, Takei, Yuji, Machida, Shizuo, Taneichi, Akiyo, Mizukami, Hiroaki, Sato, Yasufumi, Matsubara, Shigeki, Fujiwara, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970829/ https://www.ncbi.nlm.nih.gov/pubmed/26893100 http://dx.doi.org/10.1111/cas.12911

Ejemplares similares

The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
por: TAKAHASHI, YOSHIFUMI, et al.
Publicado: (2015)

Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer
por: Koyanagi, Takahiro, et al.
Publicado: (2021)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Disseminated Intravascular Coagulopathy Caused by Uterine Leiomyoma with Sarcoma-Like Findings on Magnetic Resonance Imaging
por: Taneichi, Akiyo, et al.
Publicado: (2014)

Community-Based Interventions to Improve HPV Vaccination Coverage among 13- to 15-Year-Old Females: Measures Implemented by Local Governments in Japan
por: Fujiwara, Hiroyuki, et al.
Publicado: (2013)

Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trial
por: Fujiwara, Hiroyuki, et al.
Publicado: (2015)

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)

Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report
por: Umihira, Shuntaro, et al.
Publicado: (2022)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
por: WANG, DONGDONG, et al.
Publicado: (2011)

Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation
por: SATO, NAOTO, et al.
Publicado: (2012)

CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
por: Yoshiba, Takahiro, et al.
Publicado: (2019)

Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice
por: Song, Kang-Moon, et al.
Publicado: (2021)

The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway
por: WANG, DONGDONG, et al.
Publicado: (2016)

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
por: Masuda, Kana, et al.
Publicado: (2018)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo
por: Kern, Johann, et al.
Publicado: (2009)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
por: Watatani, Hiroyuki, et al.
Publicado: (2014)

Requisite role of vasohibin‐2 in spontaneous gastric cancer formation and accumulation of cancer‐associated fibroblasts
por: Suzuki, Yasuhiro, et al.
Publicado: (2017)

Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer
por: Kobayashi, Hiroaki, et al.
Publicado: (2017)

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis
por: Kitahara, Shuji, et al.
Publicado: (2014)

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020)

Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan
por: Kobayashi, Hiroaki, et al.
Publicado: (2021)

Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
por: Miyashita, Hiroki, et al.
Publicado: (2012)

High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
por: Watanabe, Tatsuaki, et al.
Publicado: (2018)

Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1
por: Zhou, Shi-you, et al.
Publicado: (2010)

Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization
por: Onami, Hideyuki, et al.
Publicado: (2013)

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2
por: Horie, Sachiko, et al.
Publicado: (2023)

The crystal structure of the tetrameric human vasohibin-1–SVBP complex reveals a variable arm region within the structural core
por: Ikeda, Akihito, et al.
Publicado: (2020)

Vasohibin-1 suppresses colon cancer
por: Liu, Shuai, et al.
Publicado: (2015)

Structural basis of tubulin detyrosination by vasohibins
por: Li, Faxiang, et al.
Publicado: (2019)

Neutrophil extracellular traps (NETs) reduce the diffusion of doxorubicin which may attenuate its ability to induce apoptosis of ovarian cancer cells
por: Tamura, Kohei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tlf709ia92mjntft2tshgmv50